Guangdong Hybribio Biotech Co.,Ltd.
SZSE:300639.SZ
8.67 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 225.783 | 181.302 | 250.184 | 243.994 | 304.523 | 302.112 | 1,338.387 | 1,416.056 | 1,331.809 | 1,510.718 | 681.381 | 693.008 | 689.162 | 609.472 | 437.678 | 411.281 | 355.824 | 149.714 | 211.711 | 200.619 | 180.204 | 136.859 | 175.542 | 155.202 | 142.671 | 106.936 | 143.195 | 125.58 | 123.419 | 86.891 | 118.64 | 101.681 | 103.74 | 74.243 |
| Cost of Revenue
| 98.56 | 90.991 | 126.759 | 114.717 | 95.602 | 115.856 | 364.447 | 460.321 | 425.692 | 464.205 | 218.093 | 202.333 | 237.222 | 207.533 | 144.405 | 98.283 | 81.281 | 36.785 | 44.207 | 37.335 | 33.802 | 26.242 | 29.529 | 25.014 | 22.653 | 18.582 | 27.394 | 20.6 | 17.037 | 13.546 | 16.489 | 16.251 | 14.634 | 9.699 |
| Gross Profit
| 127.224 | 90.312 | 123.424 | 129.277 | 208.922 | 186.256 | 973.94 | 955.736 | 906.118 | 1,046.514 | 463.288 | 490.675 | 451.94 | 401.939 | 293.274 | 312.998 | 274.543 | 112.929 | 167.504 | 163.284 | 146.402 | 110.617 | 146.013 | 130.188 | 120.018 | 88.354 | 115.801 | 104.98 | 106.382 | 73.345 | 102.151 | 85.429 | 89.106 | 64.544 |
| Gross Profit Ratio
| 0.563 | 0.498 | 0.493 | 0.53 | 0.686 | 0.617 | 0.728 | 0.675 | 0.68 | 0.693 | 0.68 | 0.708 | 0.656 | 0.659 | 0.67 | 0.761 | 0.772 | 0.754 | 0.791 | 0.814 | 0.812 | 0.808 | 0.832 | 0.839 | 0.841 | 0.826 | 0.809 | 0.836 | 0.862 | 0.844 | 0.861 | 0.84 | 0.859 | 0.869 |
| Reseach & Development Expenses
| 21.543 | 24.296 | 29.23 | 31.201 | 33.407 | 37.747 | 87.718 | 78.929 | 51.313 | 29.322 | 35.17 | 29.802 | 23.696 | 26.627 | 28.2 | 17.551 | 13.349 | 12.523 | 17.243 | 15.995 | 15.273 | 8.936 | 14.662 | 12.97 | 18.318 | 0 | 43.55 | 7.223 | 16.301 | 0 | 31.873 | 0 | 14.514 | 0 |
| General & Administrative Expenses
| -6.932 | 55.108 | -94.525 | 138.314 | -13.616 | 58.583 | -145.273 | 236.873 | -53.024 | 104.661 | -72.736 | 136.585 | -29.586 | 54.554 | -21.753 | 32.722 | -8.723 | 26.94 | -33.816 | 31.261 | -10.901 | 32.42 | -23.986 | 26.105 | -12.756 | 29.808 | -41.814 | 27.553 | -12.032 | 25.314 | -45.402 | 22.134 | 21.315 | 22.743 |
| Selling & Marketing Expenses
| 61.725 | 53.777 | 120.875 | 56.179 | 28.785 | 73.284 | 113.069 | 47.578 | 103.629 | 195.935 | 113.395 | 95.15 | 86.876 | 87.255 | 107.793 | 81.44 | 80.134 | 43.744 | 78.562 | 69.203 | 58.454 | 54.229 | 65.301 | 57.21 | 50.313 | 44.721 | 53.524 | 47.915 | 46.518 | 35.162 | 46.245 | 39.778 | 40.448 | 33.517 |
| SG&A
| 54.793 | 98.955 | 168.069 | 194.493 | 15.169 | 131.867 | -32.203 | 284.451 | 50.605 | 300.596 | 40.659 | 231.736 | 57.289 | 141.809 | 86.041 | 114.162 | 71.411 | 70.684 | 44.746 | 100.464 | 47.553 | 86.649 | 41.315 | 83.315 | 37.558 | 74.529 | 11.711 | 75.468 | 34.486 | 60.476 | 0.843 | 61.911 | 61.764 | 56.26 |
| Other Expenses
| 0.413 | 0.081 | -32.717 | -2.649 | -2.24 | -6.824 | 249.622 | -134.982 | 139.343 | 2.651 | -17.421 | 1.014 | -0.153 | -0.039 | -2.767 | -0.741 | -1.037 | -0.319 | 0.556 | -0.844 | -0.689 | -0.753 | 1.137 | -0.263 | -0.373 | -0.577 | 0.344 | -0.291 | -0.744 | 0.126 | 1.023 | 0.568 | 2.542 | 0.375 |
| Operating Expenses
| 148.301 | 123.169 | 230.016 | 147.771 | 127.732 | 162.79 | 305.136 | 228.398 | 241.261 | 332.57 | 185.926 | 177.526 | 167.61 | 170.075 | 181.577 | 131.368 | 122.86 | 82.285 | 124.393 | 117.015 | 100.721 | 95.317 | 109.83 | 96.641 | 85.989 | 74.972 | 88.079 | 74.845 | 71.454 | 61.251 | 75.781 | 62.627 | 62.538 | 56.865 |
| Operating Income
| -99.819 | -32.858 | -106.591 | 2.759 | 64.387 | 60.644 | 225.352 | 658.02 | 637.473 | 672.325 | 265.111 | 317.51 | 264.316 | 226.842 | 114.68 | 179.047 | 145.185 | 29.927 | 44.672 | 46.911 | 47.443 | 17.227 | 40.147 | 33.996 | 38.143 | 13.728 | 30.865 | 33.221 | 34.413 | 11.567 | 24.995 | 21.86 | 25.621 | 7.954 |
| Operating Income Ratio
| -0.442 | -0.181 | -0.426 | 0.011 | 0.211 | 0.201 | 0.168 | 0.465 | 0.479 | 0.445 | 0.389 | 0.458 | 0.384 | 0.372 | 0.262 | 0.435 | 0.408 | 0.2 | 0.211 | 0.234 | 0.263 | 0.126 | 0.229 | 0.219 | 0.267 | 0.128 | 0.216 | 0.265 | 0.279 | 0.133 | 0.211 | 0.215 | 0.247 | 0.107 |
| Total Other Income Expenses Net
| 0.413 | -0.338 | 22.351 | -2.649 | -2.24 | -1.67 | -36.475 | -5.965 | -21.542 | -1.321 | -17.421 | 5.375 | -20.167 | -5.06 | 0.216 | -3.324 | -7.535 | -1.035 | 2.116 | -0.203 | 1.073 | 1.175 | 5.102 | 0.186 | 3.741 | -0.231 | 3.486 | 2.795 | -1.263 | -0.402 | -0.373 | -0.375 | 1.576 | 0.65 |
| Income Before Tax
| -99.406 | -33.196 | -84.24 | 0.109 | 62.147 | 58.974 | 188.877 | 652.055 | 615.931 | 671.003 | 247.69 | 318.524 | 264.162 | 226.804 | 111.913 | 178.307 | 144.148 | 29.608 | 45.227 | 46.067 | 46.754 | 16.474 | 41.284 | 33.733 | 37.77 | 13.151 | 31.208 | 32.93 | 33.666 | 11.693 | 25.997 | 22.428 | 28.145 | 8.329 |
| Income Before Tax Ratio
| -0.44 | -0.183 | -0.337 | 0 | 0.204 | 0.195 | 0.141 | 0.46 | 0.462 | 0.444 | 0.364 | 0.46 | 0.383 | 0.372 | 0.256 | 0.434 | 0.405 | 0.198 | 0.214 | 0.23 | 0.259 | 0.12 | 0.235 | 0.217 | 0.265 | 0.123 | 0.218 | 0.262 | 0.273 | 0.135 | 0.219 | 0.221 | 0.271 | 0.112 |
| Income Tax Expense
| 2.151 | -5.701 | -36.254 | -27.207 | 19.096 | 12.667 | -1.562 | 108.727 | 100.014 | 119.286 | 46.242 | 45.594 | 41.802 | 38.607 | 16.672 | 26.999 | 20.799 | 4.849 | 6.393 | 5.746 | 4.79 | 0.638 | 8.794 | 2.986 | 5.218 | 2.198 | 2.926 | 6.091 | 6.362 | 2.355 | 1.346 | 3.862 | 4.086 | 1.041 |
| Net Income
| -62.574 | -14.355 | -31.631 | 49.26 | 57.489 | 46.307 | 237.29 | 509.856 | 478.587 | 499.726 | 205.238 | 255.901 | 219.081 | 171.94 | 89.369 | 144.308 | 109.246 | 19.739 | 42.295 | 45.123 | 42.794 | 17.079 | 35.561 | 32.226 | 33.992 | 12.302 | 28.03 | 27.603 | 27.764 | 9.813 | 23.429 | 19.206 | 24.894 | 8.566 |
| Net Income Ratio
| -0.277 | -0.079 | -0.126 | 0.202 | 0.189 | 0.153 | 0.177 | 0.36 | 0.359 | 0.331 | 0.301 | 0.369 | 0.318 | 0.282 | 0.204 | 0.351 | 0.307 | 0.132 | 0.2 | 0.225 | 0.237 | 0.125 | 0.203 | 0.208 | 0.238 | 0.115 | 0.196 | 0.22 | 0.225 | 0.113 | 0.197 | 0.189 | 0.24 | 0.115 |
| EPS
| -0.098 | -0.022 | -0.049 | 0.076 | 0.089 | 0.071 | 0.36 | 1.17 | 1.1 | 1.15 | 0.46 | 0.87 | 0.74 | 0.26 | 0.34 | 0.24 | 0.4 | 0.032 | 0.16 | 0.075 | 0.15 | 0.028 | 0.13 | 0.053 | 0.13 | 0.021 | 0.1 | 0.045 | 0.14 | 0.022 | 0.12 | 0.042 | 0.12 | 0.019 |
| EPS Diluted
| -0.098 | -0.022 | -0.049 | 0.076 | 0.089 | 0.071 | 0.36 | 1.17 | 1.1 | 1.15 | 0.46 | 0.87 | 0.74 | 0.26 | 0.34 | 0.24 | 0.4 | 0.032 | 0.16 | 0.075 | 0.15 | 0.025 | 0.13 | 0.053 | 0.13 | 0.021 | 0.1 | 0.045 | 0.14 | 0.022 | 0.12 | 0.042 | 0.12 | 0.019 |
| EBITDA
| -14.802 | -43.324 | -57.739 | -17.118 | 62.034 | 45.481 | 684.769 | 691.684 | 646.951 | 718.538 | 270.439 | 320.97 | 281.888 | 240.856 | 113.061 | 183.998 | 151.258 | 31.395 | 47.091 | 46.835 | 48.276 | 17.146 | 46.668 | 34.17 | 38.877 | 14.471 | 33.691 | 30.705 | 34.293 | 12.537 | 29.175 | 23.265 | 27.116 | 7.964 |
| EBITDA Ratio
| -0.066 | -0.239 | -0.231 | -0.07 | 0.204 | 0.151 | 0.512 | 0.488 | 0.486 | 0.476 | 0.397 | 0.463 | 0.409 | 0.395 | 0.258 | 0.447 | 0.425 | 0.21 | 0.222 | 0.233 | 0.268 | 0.125 | 0.266 | 0.22 | 0.272 | 0.135 | 0.235 | 0.245 | 0.278 | 0.144 | 0.246 | 0.229 | 0.261 | 0.107 |